PROTEINA
PROTEINA provides quantitative measurement and analysis of protein–protein interactions at single-molecule resolution to inform drug discovery, diagnostics, and basic research. The company’s core SPID platform and proprietary single-molecule co‑immunoprecipitation technology capture and quantify individual PPIs, combined with analytic models and AI-enabled antibody discovery tools to translate PPI metrics into efficacy predictions. PROTEINA operates as a B2B biotech platform offering assay development and analytic services for pharmaceutical, diagnostic, and academic customers. The platform emphasizes precise, high-throughput PPI assays and computational modeling to accelerate target validation and candidate selection. PROTEINA targets markets in drug discovery, diagnostic development, and molecular research where quantitative PPI data improve decision making.
PROTEINA
PROTEINA provides quantitative measurement and analysis of protein–protein interactions at single-molecule resolution to inform drug discovery, diagnostics, and basic research. The company’s core SPID platform and proprietary single-molecule co‑immunoprecipitation technology capture and quantify individual PPIs, combined with analytic models and AI-enabled antibody discovery tools to translate PPI metrics into efficacy predictions. PROTEINA operates as a B2B biotech platform offering assay development and analytic services for pharmaceutical, diagnostic, and academic customers. The platform emphasizes precise, high-throughput PPI assays and computational modeling to accelerate target validation and candidate selection. PROTEINA targets markets in drug discovery, diagnostic development, and molecular research where quantitative PPI data improve decision making.